Banner AI technology

Prometheus MedTech AI is the only startup from Poland to meet with an Intel representative

The Institute of Mother and Child hosted an extraordinary meeting on the future of technology in healthcare, attended by distinguished guests!

Prometheus MedTech AI was the only startup from Poland to participate in discussions about supporting new technologies with Intel, one of the most powerful new-tech companies in the world. Last week, its Chief Information Officer (CIO), Motti Finkelstein, visited Poland.

At the meeting at the Mother and Child Institute, Prometheus Med Tech.AI MedTech AI was represented by its founders: Witor Strzelczyk, Tomasz Bartosiak, and Paweł Kuśmierowski.

The discussions on the future of healthcare technology in the Polish market also included representatives from Intel’s Polish management team, Ricoh USA, Inc., Simplicity Consulting Sp. z o.o., Prometheus MedTech.AI, as well as the directors and representatives of the Department of Artificial Intelligence and Medical Technology Innovation at the Mother and Child Institute.

Since 2024, our startup has been collaborating with IMiD, which has long been committed to innovation and modern technologies to provide patients with access to the best medical care. The Institute is also the initiator and coordinator of the annual MCSC Hospital Leadership Innovation competition for medical startups.

Motti Finkelstein, Chief Information Officer (CIO) at Intel Corporation, is responsible for digital strategies, AI transformation, and collaboration with the startup sector. Intel has been investing in groundbreaking medical technologies for years. The company recognizes AI’s potential in diagnostics, and its capabilities in data analysis, machine learning, and hospital system integration can be key to many innovative projects.

This was the first meeting with enormous potential for collaboration between medicine and technology.

Get to know us

Photo - Main Award at Deeptech Accelerator DemoDay for Kardiodiagnostic AI

Main Award at Deeptech Accelerator DemoDay for Kardiodiagnostic AI

Prometheus MedTech.AI received the Main Award at the Deeptech Accelerator DemoDay held during the Podkarpackie Science and Innovation Festival in…

more +
Photo - PrAViC: real-time video classification with early, confident decisions presented at ECAI 2025

PrAViC: real-time video classification with early, confident decisions presented at ECAI 2025

At ECAI 2025 in Bologna — Europe’s leading conference dedicated to artificial intelligence — we presented PrAViC, a probabilistic framework…

more +
Photo - Finalist in the 8th ING Grant Program — Advancing AI for Early Cardiac Screening

Finalist in the 8th ING Grant Program — Advancing AI for Early Cardiac Screening

We’re proud to share that Prometheus MedTech.AI has been selected as a finalist in the 8th Edition of the ING Polska…

more +
Photo - “Visionary of the Polish Economy” Award for Prometheus MedTech.AI at BCC For The Future Conference

“Visionary of the Polish Economy” Award for Prometheus MedTech.AI at BCC For The Future Conference

We’re proud to share that Prometheus MedTech.AI has received the “Visionary of the Polish Economy” Award named after Marek Goliszewski, presented…

more +
Photo - Top 3 in AI in Healthcare & Top 15 Medical Startups 2025 at MEDICA Innovation World Cup

Top 3 in AI in Healthcare & Top 15 Medical Startups 2025 at MEDICA Innovation World Cup

We’re proud to be ranked among the Top 3 AI startups in healthcare globally and the Top 15 medical startups overall…

more +
Photo - Prometheus MedTech.AI selected to Top 40 out of 2,626 startups worldwide in Korea’s K-Startup Grand Challenge 2025!

Prometheus MedTech.AI selected to Top 40 out of 2,626 startups worldwide in Korea’s K-Startup Grand Challenge 2025!

Prometheus MedTech.AI has been named one of the Top 40 most promising startups in the prestigious K-Startup Grand Challenge 2025 (KSGC) —…

more +
Photo - Prometheus MedTech.AI at NeoHeart 2025: A Milestone Toward U.S. Market Entry

Prometheus MedTech.AI at NeoHeart 2025: A Milestone Toward U.S. Market Entry

Prometheus MedTech.AI has taken a major step toward its U.S. market entry and future FDA certification by participating in NeoHeart 2025…

more +
Photo - Ultra Echo Scan Among Top 3% of Global Startups – Prometheus MedTech.AI Joins K-Startup Grand Challenge 2025!

Ultra Echo Scan Among Top 3% of Global Startups – Prometheus MedTech.AI Joins K-Startup Grand Challenge 2025!

We’re proud to announce that our innovative solution, Ultra Echo Scan (UES), has been selected among the Top 80 startups worldwide for the…

more +
Photo - Prometheus MedTech.AI Expands U.S. Presence with Clinical Collaborations in New York

Prometheus MedTech.AI Expands U.S. Presence with Clinical Collaborations in New York

We are pleased to announce that the Prometheus MedTech.AI team has recently completed a productive visit to New York City, marking…

more +
Photo - Prometheus MedTech.AI at South Summit 2025: A Milestone in Our Global Journey

Prometheus MedTech.AI at South Summit 2025: A Milestone in Our Global Journey

From the Top 10 Health Startups in Europe to the stage in Madrid — our team joined one of the world’s most prestigious innovation summits to connect, pitch, and share our mission.

more +
Photo - International Expansion of Ultra Echo Scan Supported by EU Funding

International Expansion of Ultra Echo Scan Supported by EU Funding

We are proud to announce that UES Sp. z o.o. has received European Union funding to support the international expansion of our…

more +
Photo - Prometheus MedTech.AI Recognized Among Top 10 Health Startups at South Summit Madrid 2025

Prometheus MedTech.AI Recognized Among Top 10 Health Startups at South Summit Madrid 2025

We are thrilled to announce that Prometheus MedTech.AI has been selected as one of the Top 10 startups in the Health category at South Summit…

more +
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.